Benefit of long-term treatment with teriflunomide on disability outcomes: results from TEMSO and TOWER

被引：0
|
作者：
Lublin, F. [1 ]
Freedman, M. S. [2 ,3 ]
Comi, G. [4 ]
Miller, A. E. [5 ]
Thangavelu, K. [6 ]
Truffinet, P. [7 ]
Kappos, L. [8 ]
机构：
[1] Icahn Sch Med Mt Sinai, Corinne Goldsmith Dickinson Ctr MS, New York, NY 10029 USA
[2] Univ Ottawa, Ottawa, ON, Canada
[3] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[6] Sanofi Genzyme, Cambridge, MA USA
[7] Sanofi Genzyme, Chilly Mazarin, France
[8] Univ Hosp Basel, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
基金：
新加坡国家研究基金会; 美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P691
引用
收藏
页码：333 / 334
页数：2
相关论文
共 50 条
  • [41] Effect of teriflunomide on relapses leading to healthcare resource use: results from the TEMSO study
    O'Connor, P.
    Lublin, F.
    Wolinsky, J.
    Comi, G.
    Kappos, L.
    Freedman, M.
    Olsson, T.
    Miller, A.
    Burrell, A.
    Dive-Pouletty, C.
    Grand, A.
    Confavreux, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S95 - S96
  • [42] Utilizing brain volume loss as an additional predictor of long-term treatment outcomes: analysis of TEMSO MRI SIENA data
    Sormani, M. P.
    Wuerfel, J.
    Thangavelu, K.
    De Stefano, N.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 364 - 364
  • [43] Effect of Teriflunomide on substantial disability worsening in patients with relapsing forms of MS in a Pooled Analysis of the phase-3 TEMSO and TOWER studies
    Kappos, L.
    Miller, A.
    Poole, E.
    Chavin, J.
    Truffinet, P.
    Freedman, M. S.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 433 - 433
  • [44] Outcomes in Patients with Progressive MS: Analysis of Teriflunomide Long-Term Extension Data
    Nelson, Flavia
    Lebrun-Frenay, Christine
    Camu, William
    Boyko, Alexey
    Thangavelu, Karthinathan
    Rufi, Pascal
    Cavalier, Steve
    Truffinet, Philippe
    Liang, Jinjun
    Lublin, Fred
    [J]. NEUROLOGY, 2016, 86
  • [45] Measurement and outcomes from long-term psychotherapy treatment
    Lundblad, SBG
    [J]. INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2000, 35 (3-4) : 260 - 261
  • [46] Teriflunomide: pooled hepatic safety outcomes from placebo-controlled studies and long-term extensions
    Marziniak, M.
    Freedman, M. S.
    Benamor, M.
    Truffinet, P.
    Thangavelu, K.
    Leist, T. P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 201 - 201
  • [47] RESULTS OF LONG-TERM HOME NURSING - INFLUENCE OF DISABILITY
    FORD, AB
    KATZ, S
    DOWNS, TD
    ADAMS, M
    [J]. JOURNAL OF CHRONIC DISEASES, 1971, 24 (09): : 591 - &
  • [48] Long-term outcomes of radiofrequency treatment for fecal incontinence: are the results maintainable?
    Omar Vergara-Fernandez
    Jose Armando Arciniega-Hernández
    Mario Trejo-Avila
    [J]. International Journal of Colorectal Disease, 2020, 35 : 173 - 176
  • [49] Long-term outcomes of radiofrequency treatment for fecal incontinence: are the results maintainable?
    Vergara-Fernandez, Omar
    Armando Arciniega-Hernandez, Jose
    Trejo-Avila, Mario
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (01) : 173 - 176
  • [50] Treatment adherence and long-term outcomes
    Kane, John M.
    [J]. CNS SPECTRUMS, 2007, 12 (10) : 21 - 26
12345